Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line

International Journal of Cancer

Volumn 65, Issue 4, 1996, Pages 485-490

  Battelli, Maria Giulia ^a,c   Polito, Letizia ^a   Bolognesi, Andrea ^a   Lafleur, Louis ^b   Fradet, Yves ^b   Stirpe, Fiorenzo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b LAVAL UNIVERSITY   (Canada)

^c Dipto di Patologia Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOTOXIN; MOMORDIN; MONOCLONAL ANTIBODY; POKEWEED ANTIVIRUS PROTEIN; RIBOSOME INACTIVATING PROTEIN; SAPORIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CARCINOMA CELL; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

HUMANS; IMMUNOTOXINS; N-GLYCOSYL HYDROLASES; PLANT PROTEINS; PROTEIN BIOSYNTHESIS; RIBOSOMES; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0029991101     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960208)65:4<485::AID-IJC16>3.0.CO;2-9     Document Type: Article

References (29)

1. BAMIAS, A., BOWLES, M.J., KRAUSZ, T., WILLIAMS, G. and EPENETOS, A.A., Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas. Int. J. Cancer, 54, 899-903 (1993).
2. BAMIAS, A., KEANE, P., KRAUSZ, T., WILLIAMS, G. and EPENETOS, A.A., Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma. Cancer Res., 51, 724-728 (1991).
3. BARBIERI, L., BATTELLI, M.G. and STIRPE, F., Ribosome-inactivating proteins from plants. Biochim biophys. Acta, 1154, 237-282 (1993).
4. BARBIERI. L., STOPPA, C. and BOLOGNESI, A., Large scale chromatographic purification of ribosome-inactivating proteins. J. Chromatogr., 408, 235-243 (1987).
5. BOLOGNESI, A., OLIVIERI, F., BATTELLI, M.G., BARBIERI, L., FALASCA, A.I., PARENTE, A., DEL VECCHIO BLANCO, F. and STIRPE, F., Ribosome-inactivating proteins (RNA N-glycosidases) from the seeds of Saponaria ocymoides and Vaccaria pyramidata. Europ. J. Biochem., 228, 935-940 (1995).
6. BOLOGNESI, A., TAZZARI, P.L., TASSI, M., GROMO, G., GOBBI, M. and STIRPE, F., Comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies. Clin. exp. Immunol., 89, 341-346 (1992).
7. BUBENIK, J., BARESOVA, M., VIKLICKY, V., JAKOUBKOVA, J., SAINEROVA, H. and DONNER, J., Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int. J. Cancer, 11, 765-773 (1974).
8. BUCKMAN, R., MCILHINNEY, R.A.J., SHEPHERD, V., PATEL, S., COOMBES, R.C. and NEVILLE, A.M., Elimination of carcinoma cells from human bone marrow. Lancet, 2, 1428-1430 (1982).
9. BURTON, K., A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J, 62, 315-322 (1956).
10. DE HARVEN, E., FRADET, Y., CONNOLLY, J.G., HANNA, W., HE, S.M., WANG, Y.C., CHOI, B.C.K., MCGROARY, R., BOOTSMA, G., TILUPS, A, and CHRISTENSEN, H., Antibody drug carrier for immunotherapy of superficial bladder cancer. Ultrastructural studies. Cancer Res., 52, 3131-3137 (1992).
11. FALINI, B.A. and 14 OTHERS, Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet, 339, 1195-1196 (1992).
12. FRADET, Y., CORDON-CARDO, C., THOMSON, T., DALY, M.E., WHITMORE, W.F., JR., LLOYD, K.O., MELAMED, M.R. and OLD. L.J., Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc. nat. Acad. Sci. (Wash.), 81, 224-228 (1984).
13. FRADET, Y., CORDON-CARDO, C., WHITMORE, W.F., JR., MELAMED, M.R. and OLD, L.J., Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics. Cancer Res., 46, 5183-5188 (1986).
14. FRADET, Y., FRIEDE, J., GUERTIN, B., LECLERC, J., DUFOUR, C. and CARON, C., Radioimmunodetection of human bladder tumor xenografts in nude mice with radiolabeled monoclonal antibodies. J. Urol., 148, 418-422 (1992).
15. GAUTHIER, J. and FRADET, Y., Growth-regulated surface glycoproteins of human bladder cancer. Cancer Res., 50, 293-298 (1990).
16. LAMM, D.L. and GRIFFITH, J.G., Intravesical therapy: does it affect the natural history of superficial bladder cancer? Semin Urol., 10, 39-44 (1992).
17. LEAMON, C.P. and Low, P.S., Cytotoxicity of momordin-folate conjugates in cultured human cells. J. biol. Chem., 267, 24966-24971 (1992).
18. MASUKO, T., YAGITA, H. and HASHIMOTO, Y., Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells. J. nat. Cancer Inst., 72, 523-530 (1984).
19. RAMAKRISHNAN, S., Cytotoxic conjugates, R.G. Landes, Austin, Texas (1993).
20. SALEH, M.N., KHAZAELI, M.B., GRIZZLE, W.E., WHEELER, R.H., LAWSON, S., LIU, T.P., RUSSELL, C., MEREDITH, R., SCHLOM, J. and LOBUGLIO, A.F., A phase-I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer. Cancer Res , 53, 4555-4562 (1993).
21. SAROSDY, M.F., HUTZLER, D.H., YEE, D. and VON HOFF, D.D., In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity. J. Urol., 150, 1950-1955 (1993).
22. SCHWARTING, R., GERDES, J., DURKOP, H., FALINI, B., PILERI, S. and STEIN, H., Ber-H2: a new anti-K1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood. 74, 1678-1689 (1989).
23. STROCCHI, P., BARBIERI, L. and STIRPE, F., Immunological properties of ribosome-inactivating proteins and of a saporin-IgG conjugate. J. immunol. Meth., 115, 57-63 (1992).
24. + lymphoma. In vitro evaluation. Brit. J. Haematol, 81, 203-211 (1992).
25. THEUER, C.P., FITZGERALD, D.J. and PASTAN, I., A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer J. Urol., 149, 1626-1632 (1993).
26. THIESEN, H.-J., JUHL, H. and ARNDT, R., Selective killing of human bladder cancer cells by combined treatment with A and B chain ricin conjugates. Cancer Res., 47, 419-423 (1987).
27. VAN OOSTERHOUT, Y.V.J.M., PREIJERS, F.W.M.B., WESSELS, J.M.C. and DE WITTE, T., Cytotoxicity of CD3-ricin A immunotoxins in relation to cellular uptake and degradation. Cancer Res., 52, 5921-5925 (1992).
28. WAWRZYNCZAK, E.J., CUMBER, A.J., HENRY. R.J., MAY, J., NEWELL, D.R., PARNELL, G.D., WORRELL, N.R. and FORRESTER, J.A., Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Cancer Res., 50, 7519-7526 (1990).
29. YOUNG, D.A . PROUT, G.R., JR. and LIN, C.-W., Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens. Cancer Res.. 45, 4439-4446 (1985).